Study: Osteoporosis drug reduces bone loss, tumor size in oral cancer
Monday, December 13, 2010 - 13:33
in Health & Medicine
A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone.